Sven Stadlbauer

Dresden, SN 01062, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Diagnostic Twins: Exploring the Radiohybrid Concept with Iodine-123 and Lanthanum-133 for PSMA-Targeted SPECT and PET Imaging.

Diagnostic Twins: Exploring the Radiohybrid Concept with Iodine-123 and Lanthanum-133 for PSMA-Targeted SPECT and PET Imaging.

Journal: Journal of medicinal chemistry

Published: April 16, 2026

Novel immunotheranostic FAP-inhibitor target modules for imaging and elimination of FAP-positive cells by UniCAR T-cells.

Novel immunotheranostic FAP-inhibitor target modules for imaging and elimination of FAP-positive cells by UniCAR T-cells.

Journal: Oncoimmunology

Published: December 15, 2025

PSMA-targeting hybrid molecule PSMA-914 for preoperative imaging and intraoperative fluorescence-guidance: A first-in-human experience.

PSMA-targeting hybrid molecule PSMA-914 for preoperative imaging and intraoperative fluorescence-guidance: A first-in-human experience.

Journal: Theranostics

Published: December 12, 2025

Heavy Alkaline Earth Radiometals for Cancer Theranostics: Coordination and Radiochemistry of Radium-223 and Barium-131 with Kryptofix 22-Based Chelators.

Heavy Alkaline Earth Radiometals for Cancer Theranostics: Coordination and Radiochemistry of Radium-223 and Barium-131 with Kryptofix 22-Based Chelators.

Journal: Inorganic chemistry

Published: November 06, 2025

"Precision on Two Wheels"─Structural Refinement of 64Cu- and 68Ga-Labeled Bicyclic Peptides Targeting Nectin-4 for Improved Tumor Imaging: From Preclinical Development to First-in-Human Application.

"Precision on Two Wheels"─Structural Refinement of 64Cu- and 68Ga-Labeled Bicyclic Peptides Targeting Nectin-4 for Improved Tumor Imaging: From Preclinical Development to First-in-Human Application.

Journal: Journal of medicinal chemistry

Published: October 13, 2025

In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency.

In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 01, 2025

Synthesis and preclinical evaluation of FAP-targeting radiotracers for PET and optical imaging.

Synthesis and preclinical evaluation of FAP-targeting radiotracers for PET and optical imaging.

Journal: EJNMMI radiopharmacy and chemistry

Published: July 21, 2025

PET and SPECT Tracer Development via Copper-Mediated Radiohalogenation of Divergent and Stable Aryl-Boronic Esters.

PET and SPECT Tracer Development via Copper-Mediated Radiohalogenation of Divergent and Stable Aryl-Boronic Esters.

Journal: Pharmaceutics

Published: June 06, 2025

Structure-activity relationship of 18F-labeled PD-L1-targeting small molecule ligands: impact of radiolabeling strategy on affinity and in vivo performance.

Structure-activity relationship of 18F-labeled PD-L1-targeting small molecule ligands: impact of radiolabeling strategy on affinity and in vivo performance.

Journal: EJNMMI radiopharmacy and chemistry

Published: May 05, 2025

It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies.

It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies.

Journal: EJNMMI radiopharmacy and chemistry

Published: April 22, 2025

Design, Synthesis, and Biological Evaluation of Small-Molecule-Based Radioligands with Improved Pharmacokinetic Properties for Imaging of Programmed Death Ligand 1.

Design, Synthesis, and Biological Evaluation of Small-Molecule-Based Radioligands with Improved Pharmacokinetic Properties for Imaging of Programmed Death Ligand 1.

Journal: Journal of medicinal chemistry

Published: December 01, 2023

Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands.

Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands.

Journal: EJNMMI radiopharmacy and chemistry

Published: October 24, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026